Skip to content
TSK Laboratory America TSK Laboratory America
  • Home
  • Products
  • Markets
    • Aesthetic
    • Ophthalmic
    • Pain Management
    • Diabetes
    • Orthapedics
    • Vaccination
  • Partnerships
  • News
  • About us
  • Contact
Log in
No account yet? Create Account
TSK Laboratory America TSK Laboratory America
  • Home
  • Products
  • Markets
    • Aesthetic
    • Ophthalmic
    • Pain Management
    • Diabetes
    • Orthapedics
    • Vaccination
  • Partnerships
  • News
  • About us
  • Contact
Search
Log in Create Account
Cart
0 0 items
Home
News

News

Safeguarding the Ocular Micro-Dose: Why Needle Geometry Matters in Ophthalmic Gene Therapy

Safeguarding the Ocular Micro-Dose: Why Needle Geometry Matters in Ophthalmic Gene Therapy

Protecting gene therapies & viral vectors (AAV's) from shear & adherence.

Michael O'Dowd
Updated on May 18, 2026

Contact

TSK Laboratory America

Presented by:
Acollaboratory America Inc.
19405 - 68th Drive NE
Suite Farlington WA 98223
United States

+1-888-287-5084

salesus@tsklab.com

Contact

TSK Laboratory America

Presented by:
Acollaboratory America Inc.
19405 - 68th Drive NE
Suite Farlington WA 98223
United States

+1-888-287-5084

salesus@tsklab.com

Account

  • Back to the Shop
  • My Account
  • Orders

Account

  • Back to the Shop
  • My Account
  • Orders

Support

  • Shipping Policy
  • Return Policy
  • Privacy Policy
  • Terms & Conditions
  • Contact

Support

  • Shipping Policy
  • Return Policy
  • Privacy Policy
  • Terms & Conditions
  • Contact

Subscribe for news and updates

© 2026 TSK Laboratory America.
  • Choosing a selection results in a full page refresh.

Created by EasyFlow Product Options